Tuesday - October 20, 2026

Progressive Supranuclear Palsy Market to Witness Growth Through 2036, Driven by Emerging Therapies and Pipeline Advancements

Progressive Supranuclear Palsy, also known as Steele-Richardson-Olszewski syndrome, is a rare neurodegenerative disorder belonging to a group of diseases called tauopathies. The disease is believed to result from abnormal accumulation of tau protein in the basal ganglia and brainstem, leading … Continue reading →

Chronic Gout Market is Projected to Grow by 2036 Owing to the Advancement of Novel Therapies | DelveInsight

The market dynamics for Chronic Gout are expected to witness growth driven by the rising burden of gout, increasing recognition of treatment-resistant disease, and the need for effective long-term urate-lowering therapies. Additionally, the development of emerging therapies such as pozdeutinurad … Continue reading →

Food Allergy Market is Projected to Boom by 2036 Owing to the Advancement of Novel Immunotherapies | DelveInsight

The market dynamics for Food Allergy are expected to witness significant growth driven by the rising prevalence of food allergies, increasing awareness and diagnosis, and the growing demand for effective treatments to prevent severe allergic reactions. Additionally, the development of … Continue reading →

Axial Spondyloarthritis Market to Expand Rapidly with Advancing Pipeline and Increasing Treatment Adoption by 2034 – DelveInsight | Janssen Pharma, Pfizer, UCB Biopharma, Celgene, Inmagene Biopharma

The Key Axial Spondyloarthritis Companies in the market include – Janssen Pharmaceuticals, Pfizer, UCB Biopharma, Celgene, Inmagene Biopharmaceuticals, Galapagos NV, Kyowa Kirin Co., Ltd., Eli Lilly and Company, Merck Sharp & Dohme LLC, Pfizer, Novartis, Jiangsu HengRui Medicine, UCB Biopharma, … Continue reading →